Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAP3K2 Antikörper

MAP3K2 Reaktivität: Human ELISA, ICC Wirt: Maus Monoclonal 4B4 unconjugated
Produktnummer ABIN969272
  • Target Alle MAP3K2 Antikörper anzeigen
    MAP3K2 (Mitogen-Activated Protein Kinase Kinase Kinase 2 (MAP3K2))
    Reaktivität
    • 46
    • 29
    • 14
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 45
    • 2
    Maus
    Klonalität
    • 38
    • 9
    Monoklonal
    Konjugat
    • 20
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser MAP3K2 Antikörper ist unkonjugiert
    Applikation
    • 29
    • 20
    • 14
    • 4
    • 3
    • 2
    • 1
    • 1
    ELISA, Immunocytochemistry (ICC)
    Verwendungszweck
    MAP3K2 Antibody
    Aufreinigung
    Ascitic fluid
    Immunogen
    Purified recombinant fragment of human MAP3K2 expressed in E. Coli.
    Klon
    4B4
    Isotyp
    IgG1
  • Applikationshinweise

    ELISA: 1/10000

    ICC: 1/200 - 1/1000

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Kurada, Li, Mulherkar, Subramanian, Prasad, Prabhakar: "MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment." in: The Journal of biological chemistry, Vol. 284, Issue 20, pp. 13533-41, (2009) (PubMed).

    Cazares, Troyer, Mendrinos, Lance, Nyalwidhe, Beydoun, Clements, Drake, Semmes: "Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, Issue 17, pp. 5541-51, (2009) (PubMed).

  • Target
    MAP3K2 (Mitogen-Activated Protein Kinase Kinase Kinase 2 (MAP3K2))
    Andere Bezeichnung
    MAP3K2 (MAP3K2 Produkte)
    Synonyme
    Mekk2 antikoerper, MEKK2 antikoerper, MEKK2B antikoerper, 9630061B06Rik antikoerper, AI585793 antikoerper, Mekk2b antikoerper, mitogen activated protein kinase kinase kinase 2 antikoerper, mitogen-activated protein kinase kinase kinase 2 antikoerper, Map3k2 antikoerper, MAP3K2 antikoerper
    Hintergrund

    Description: The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase preferentially activates other kinases involved in the MAP kinase signaling pathway. This kinase has been shown to directly phosphorylate and activate Ikappa B kinases, and thus plays a role in NF-kappa B signaling pathway. This kinase has also been found to bind and activate protein kinase C-related kinase 2, which suggests its involvement in a regulated signaling process.

    Aliases: MEKK2, MEKK2B

    Molekulargewicht
    70kDa
    Gen-ID
    10746
    HGNC
    10746
    UniProt
    Q9Y2U5
    Pathways
    MAPK Signalweg
Sie sind hier:
Kundenservice